{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:06:16Z","timestamp":1769191576055,"version":"3.49.0"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.2169\/internalmedicine.1143-18","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T22:41:36Z","timestamp":1550184096000},"page":"593-601","source":"Crossref","is-referenced-by-count":3,"title":["Acute Pulmonary Hypertension Crisis after Adalimumab Reduction in Rheumatoid Vasculitis"],"prefix":"10.2169","volume":"58","author":[{"given":"Gentaro","family":"Yamasaki","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsumasa","family":"Okano","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoe","family":"Jimbo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Sendo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tamada","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Misaki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kita-Harima Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Shinkura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Akashi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yokozaki","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Emoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"},{"name":"Department of Clinical Pharmacy, Kobe Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Castro GWR, Appenzeller S, Bertolo MB, Costallat LTL. Isolated pulmonary hypertension secondary to rheumatoid arthritis. Clin Rheumatol 25: 901-903, 2006.","DOI":"10.1007\/s10067-005-0089-x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Panagiotidou E, Sourla E, Kotoulas SX, et al. Rheumatoid arthritis associated pulmonary hypertension: clinical challenges reflecting the diversity of pathophysiology. Respir Med Case Reports 20: 164-167, 2017.","DOI":"10.1016\/j.rmcr.2017.02.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179: 151-157, 2009.","DOI":"10.1164\/rccm.200806-953OC"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Chung L, Liu J, Parsons L, et al. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 138: 1383-1394, 2010.","DOI":"10.1378\/chest.10-0260"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Balagopal VP, Da Costa P, Greenstone MA. Fatal pulmonary hypertension and rheumatoid vasculitis. Eur Respir J 8: 331-333, 1995.","DOI":"10.1183\/09031936.95.08020331"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kishore S, Maher L, Majithia V. Rheumatoid vasculitis: a diminishing yet devastating menace. Curr Rheumatol Rep 19: 39, 2017.","DOI":"10.1007\/s11926-017-0667-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Scott DGI, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 76: 377-384, 1984.","DOI":"10.1016\/0002-9343(84)90654-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ntatsaki E, Mooney J, Scott DGI, Watts RA. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatol (United Kingdom) 53: 145-152, 2014.","DOI":"10.1093\/rheumatology\/ket326"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Miyamichi-Yamamoto S, Fukumoto Y, Sugimura K, et al. Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease. Circ J 75: 2668-2674, 2011.","DOI":"10.1253\/circj.CJ-11-0473"},{"key":"10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/resp.12464","volume":"20","author":"S Sadeghi","year":"2015","unstructured":"10. Sadeghi S, Granton JT, Akhavan P, et al. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension. Respirology 20: 481-487, 2015.","journal-title":"Respirology","ISSN":"https:\/\/id.crossref.org\/issn\/1323-7799","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Reeves GEM, Collins N, Hayes P, et al. SAPHIRE: Stress and pulmonary hypertension in rheumatoid evaluation - a prevalence study. Int J Rheumatol 2016: 4564531, 2016.","DOI":"10.1155\/2016\/4564531"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Collins MP. The vasculitic neuropathies: an update. Curr Opin Neurol 25: 573-585, 2012.","DOI":"10.1097\/WCO.0b013e3283580432"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-\u03b1, in patients with moderate-to-severe heart failure. Circulation 107: 3133 LP-3140, 2003.","DOI":"10.1161\/01.CIR.0000077913.60364.D2"},{"key":"14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000090248","volume":"75","author":"E Bargagli","year":"2008","unstructured":"14. Bargagli E, Galeazzi M, Bellisai F, Volterrani L, Rottoli P. Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension. Respiration 75: 346-349, 2008.","journal-title":"Respiration","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7931","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhang LL, Lu J, Li MT, Wang Q, Zeng XF. Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension. Int J Rheum Dis 19: 192-198, 2016.","DOI":"10.1111\/1756-185X.12304"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gizinski AM, Fox DA. T cell subsets and their role in the pathogenesis of rheumatic disease. Curr Opin Rheumatol 26: 204-210, 2014.","DOI":"10.1097\/BOR.0000000000000036"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bonelli M, G\u00f6schl L, Bl\u00fcml S, et al. Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis. Rheumatol (United Kingdom) 55: 710-720, 2016.","DOI":"10.1093\/rheumatology\/kev403"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hernandez-Sanchez J, Harlow L, Church C, et al. Clinical trial protocol for TRANSFORM-UK: a therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension. Pulm Circ 8: 2045893217735820, 2018.","DOI":"10.1177\/2045893217735820"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/4\/58_1143-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T02:24:22Z","timestamp":1573957462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/4\/58_1143-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1143-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]}}}